[Metabolic curietherapy with P-32 in bone metastases in breast cancer].
The administration of radioactive phosphorus (P-32) for the treatment of pain in metastatic bone lesions from breast cancer shows palliative effects lasting three to nine months. The evolution of the disease is not modified.